Eisai Files Marketing Authorization Application for Anti-Amyloid-Beta Protofibril Antibody Lecanemab for Early Alzheimer’s Disease in Japan
TOKYO and CAMBRIDGE, Mass […]
Tag: treatment
Soligenix On Track to Deliver Important Front-Line Treatment to US Market in 2024
NEW YORK, NY, Jan 16, 202 […]
AJG Publishes Data from HighTide Therapeutics’ Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
ROCKVILLE, MD and SHENZHE […]
American Journal of Gastroenterology Publishes Data from HighTide Therapeutics’ Phase 2 Study of HTD1801 Treatment in Primary Sclerosing Cholangitis
ROCKVILLE, MD and SHENZHE […]
Zhaoke Ophthalmology’s Partner Vyluma Announces Positive Results from Phase III CHAMP Study of NVK002 for Treatment of Myopia Progression in Children
HONG KONG, Oct 28, 2022 & […]
ATAL’s Award-Winning AMSFS III Granted Patent in Mainland China
HONG KONG, Sep 15, 2022 & […]
Sinomab Announces IND Application of SN1011 for the Treatment of Neuromyelitis Optica Spectrum Disorder Approved by NMPA
HONG KONG, Aug 24, 2022 & […]
SinoMab Announces IND APPLICATION FOR SN1011 ACCEPTED BY NMPA CDE
Continuously expanding th […]
Memiontec Secures its Largest Contract to date following Award of a New S$56.6 Million Contract by PUB
Singapore, Mar 25, 2022 & […]
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Approved by FDA
HONG KONG, Mar 14, 2022 & […]
IND Application for SinoMab’s First-in-Class Asthma Therapeutic Product SM17 Accepted by FDA
HONG KONG, Feb 17, 2022 & […]
Biogen Announces Reduced Price for Aduhelm to Improve Access For Patients With Early Alzheimer’s Disease In The United States
TOKYO, Dec 21, 2021 ̵ […]
Eisai Enters into Commercialization and Distribution Agreement with Gilead for JAK Inhibitor Filgotinib in Asia
TOKYO, Dec 20, 2021 ̵ […]
Gradiant Secures Five New DBOOM Projects in Indonesia and Vietnam, Appoints Managing Directors to Fuel Growth
Singapore, Dec 2, 2021 &# […]
Eisai Presents Late-Breaker Updates on Lecanemab Clinical, Biomarker and Safety Data from Phase 2b Study Core and Open-Label Extension
TOKYO, Nov 11, 2021 ̵ […]
Fujitsu and Aichi Cancer Center Develop AI System to Offer Patients Personalized Cancer Treatment
TOKYO, Oct 19, 2021 ̵ […]
Gradiant Achieves Strong Growth Across Asia in Cleantech Water Treatment during the Pandemic
– Gradiant demonstrated s […]
New treatment option for schizophrenia Reagila(R) listed on PBS
MELBOURNE, Sep 6, 2021 &# […]
Eisai and Biogen Present Preliminary Assessment of the Clinical Effects of Lecanemab (BAN2401)
TOKYO, Jul 30, 2021 ̵ […]
Biogen and Eisai Announce ADUHELMTM (aducanumab-avwa) Data Presentations at Alzheimer’s Association International Conference 2021
TOKYO, Jul 27, 2021 ̵ […]
Central Global Bhd Signs MoU for JV to Build RM250M Kwasa Damansara Sewage Treatment Plant
KUALA LUMPUR, Jun 9, 2021 […]
MHIEC Supplies Incinerators for First Waste-to-Energy Plant in Xiaogan, Hubei Province, China
TOKYO, Apr 27, 2021 ̵ […]
Hua Medicine Announces Acceptance of a New Drug Application for Dorzagliatin in China – First Glucokinase Activator (GKA) Globally
SHANGHAI, CHINA, Apr 23, […]